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Skin Cancer
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Introduction. In case of superﬁcial lesions, bolus typematerials are needed. Several inconveniences are traditionally associated like
re-positioning inaccuracy, adherence lack producing airgaps, etc. A new type of high density bolus called eXaSkin (Anatomical
Geometry) is studied. Made from two components that mixed up give rise to a moldable material that can be adapted during
2m before it hardens. Its physical density of 1.6 g/cm3, remove the build-up zone for photons allowing and efﬁcient surface
irradiation. eXaSkin dosimetric properties have been studied to asses that TPS calculation of this material is correct.
Materials and methods. Radiochromic ﬁlm dosimetry has been chosen primarily for experimental set-up easiness. EBT2
radiochromic ﬁlms have a very weak dependence with energy which allows its use for percentage depth dose measurements
(PDDs). After ﬁlm calibration into solid water slabs from 0 to 600 cGy following by an absolute dosimetry to asses dose, elon-
gated cutouts are also irradiated parallel to beam axis without and with a 1 cm high bolus. Cutouts are scanned in transmission
mode and the percentage is constructed. The calculation is performed in TPS for comparison. Afterwards, a relative dosimetry
is performed, once the a experimental set-up is constructed to hold the bolus piece on the water surface. The effect of airgaps
between bolus and surface on the re-build-up is studied.
Results. PDDs curves from radiochromic ﬁlm agree with TPS calculated data which shows that this material can be calculated
correctly. The comparison of PDD curves with different airgaps show little inﬂuence up to 3 cm space in between.
Conclusion. In relation to the clinical application, until now the bolus have been use in three cases: peripherical brain tumor after
the ear, breast cancer skin relapse and basocelular facial tumor. In all these cases the standar CT showed that, independently of
the chosen technique, skin area was not covered.
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Introduction. Eccrine porocarcinoma (EP) is a rare malignant sweat gland tumor.
Objectives. To revise literature of EP, in relation to our cases.
Methods. Our cases were revised and compared with cases in the literature review (January 23rd, 2013); keywords: porocarcinoma;
radiotherapy (RT); sweat gland tumor in PubMed, Medline, EMBASE and ScIELO.
Results. Firstly, we present a 68-year-old man with cutaneous EP which, after two surgical excisions, recurred, affecting the
parotid and regional lymph nodes, treated with surgery and intensity modulated RT. Treatment volumes: pericicatricial skin
(total dose; TD: 60Gy); tumor bed (TD: 64Gy); and scalp, pre-, retro-auricular and cervical lymph node levels IB-V (TD: 60Gy),
administered in 30 fractions (simultaneous integrated boost:tumor bed). During radiotherapy a new lymphadenopathy appeared
in the left supraclavicular fossa (under treatment). Biopsy proved it positive for tumor cells. Imaging reevaluation showed no
metastases. It was boosted (5 sessions; TD: 70Gy). Toxicity scored by Radiation Therapy Oncology Group (RTOG) scoring system
wasG1 xerostomia, G2 ephiteliitis,mucositis, dysgeusia, and otalgia, andG4 otorrhea. Thepatient progressed locally andhad lung
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